Lv11
98 积分 2024-02-05 加入
Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial
53分钟前
已完结
Letter by Dai et al Regarding Article, “Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial”
4天前
已完结
Detection of arrhythmias in patients with transthyretin cardiac amyloidosis
4天前
已关闭
Safety, Pharmacokinetics, and Pharmacodynamics of SHR-2004, a Novel Humanized Monoclonal Antibody Targeting Factor XI, in Patients with Atrial Fibrillation: An Open-Label Phase 1b Study
15天前
已完结
Predictors of short-term and long-term effects of mavacamten in obstructive hypertrophic cardiomyopathy
16天前
已完结
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
22天前
已完结
Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort
23天前
已完结
Atrial fibrillation
26天前
已完结
Pelacarsen and Lp(a)HORIZON: Interpreting the Disconnect Between Lipoprotein(a) Lowering and Cardiovascular Outcomes
26天前
已完结
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
28天前
已完结